• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

前列腺MRI引导下如何改进超声引导靶向活检

How to Improve TRUS-Guided Target Biopsy following Prostate MRI.

作者信息

Park Byung Kwan

机构信息

Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

出版信息

Cancers (Basel). 2021 Nov 11;13(22):5647. doi: 10.3390/cancers13225647.

DOI:10.3390/cancers13225647
PMID:34830798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8616137/
Abstract

TRUS is a basic imaging modality when radiologists or urologists perform cognitive fusion or image fusion biopsy. This modality plays the role of the background images to add to an operator's cognitive function or MRI images. Operators need to know how to make TRUS protocols for lesion detection or targeting. Tumor location, size, and shape on TRUS are different from those on MRI because the scan axis is different. TRUS findings of peripheral or transition tumors are not well known to radiologists and urologists. Moreover, it remains unclear if systematic biopsy is necessary after a tumor is targeted. The purpose of this review is to introduce new TRUS protocols, new imaging features, new biopsy techniques, and to assess the necessity of systematic biopsy for improving biopsy outcomes.

摘要

当放射科医生或泌尿科医生进行认知融合或图像融合活检时，超声弹性成像（TRUS）是一种基本的成像方式。这种方式起到背景图像的作用，以增强操作者的认知功能或补充MRI图像。操作者需要知道如何制定用于病变检测或靶向的TRUS方案。由于扫描轴不同，TRUS上肿瘤的位置、大小和形状与MRI上的不同。放射科医生和泌尿科医生对周围型或移行型肿瘤的TRUS表现了解不足。此外，在肿瘤靶向定位后是否有必要进行系统活检仍不明确。本综述的目的是介绍新的TRUS方案、新的成像特征、新的活检技术，并评估系统活检对改善活检结果的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/a82805b6c734/cancers-13-05647-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/5a2da8a5316a/cancers-13-05647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/42de12588fd2/cancers-13-05647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/d75a70afb390/cancers-13-05647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/fac46484f39e/cancers-13-05647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/111919117136/cancers-13-05647-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/b35f2d5ff705/cancers-13-05647-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/4d074379f2fe/cancers-13-05647-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/4640f809de77/cancers-13-05647-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/ce188468be1a/cancers-13-05647-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/60c49b2b0a7c/cancers-13-05647-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/7dce3268bfab/cancers-13-05647-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/1edf70bca257/cancers-13-05647-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/a82805b6c734/cancers-13-05647-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/5a2da8a5316a/cancers-13-05647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/42de12588fd2/cancers-13-05647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/d75a70afb390/cancers-13-05647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/fac46484f39e/cancers-13-05647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/111919117136/cancers-13-05647-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/b35f2d5ff705/cancers-13-05647-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/4d074379f2fe/cancers-13-05647-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/4640f809de77/cancers-13-05647-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/ce188468be1a/cancers-13-05647-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/60c49b2b0a7c/cancers-13-05647-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/7dce3268bfab/cancers-13-05647-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/1edf70bca257/cancers-13-05647-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c2/8616137/a82805b6c734/cancers-13-05647-g013.jpg

相似文献

1
How to Improve TRUS-Guided Target Biopsy following Prostate MRI.前列腺MRI引导下如何改进超声引导靶向活检
Cancers (Basel). 2021 Nov 11;13(22):5647. doi: 10.3390/cancers13225647.
2
Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.MRI-TRUS 融合与认知配准在 MRI 靶向、TRUS 引导前列腺活检中的准确性评估。
AJR Am J Roentgenol. 2015 Jan;204(1):83-91. doi: 10.2214/AJR.14.12681.
3
Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.前瞻性随机临床试验比较了磁共振成像（MRI）引导的腔内活检与 MRI-超声融合和经直肠超声引导的前列腺活检在先前阴性活检患者中的应用。
Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.
4
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.磁共振成像靶向活检可能比标准经直肠超声引导活检更能提高显著前列腺癌检测的诊断准确性：系统评价和荟萃分析。
Eur Urol. 2015 Sep;68(3):438-50. doi: 10.1016/j.eururo.2014.11.037. Epub 2014 Dec 3.
5
Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.磁共振成像-经直肠超声融合前列腺活检中弹性与刚性图像配准的比较：系统评价和荟萃分析。
Eur Urol Focus. 2018 Mar;4(2):219-227. doi: 10.1016/j.euf.2016.07.003. Epub 2016 Jul 29.
6
Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.磁共振成像靶向、三维经直肠超声引导下前列腺癌融合活检：量化穿刺误差对诊断的影响
Med Phys. 2014 Jul;41(7):073504. doi: 10.1118/1.4883838.
7
Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?比较三种不同的磁共振成像靶向前列腺活检技术：腔内与磁共振成像-经直肠超声融合与认知配准的系统评价。哪种技术更优？
Eur Urol. 2017 Apr;71(4):517-531. doi: 10.1016/j.eururo.2016.07.041. Epub 2016 Aug 25.
8
Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.经会阴与经直肠MRI/TRUS融合靶向活检：临床显著性前列腺癌的检出率
Clin Genitourin Cancer. 2017 Feb;15(1):e33-e36. doi: 10.1016/j.clgc.2016.07.007. Epub 2016 Jul 21.
9
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.多参数 MRI 提高经直肠超声引导前列腺活检单独诊断前列腺癌的检出率：PROMIS 研究。
Health Technol Assess. 2018 Jul;22(39):1-176. doi: 10.3310/hta22390.
10
Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.根据PI-RADS分类，对既往系统性活检结果为阴性的患者进行认知性MRI-TRUS融合靶向前列腺活检。
J Chin Med Assoc. 2016 Nov;79(11):618-624. doi: 10.1016/j.jcma.2016.05.004. Epub 2016 Aug 23.

引用本文的文献

1
New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation.针对经腹会阴直肠癌根治术（Miles手术）后前列腺特异性抗原（PSA）升高男性患者的新型经会阴超声引导活检术
Insights Imaging. 2023 Mar 16;14(1):42. doi: 10.1186/s13244-023-01384-y.
2
Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI.通过结合年龄、PSA 密度和 mpMRI 开发用于预测临床显著前列腺癌的模型。
World J Surg Oncol. 2023 Mar 7;21(1):83. doi: 10.1186/s12957-023-02959-1.
3
TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.

本文引用的文献

1
New TRUS Techniques and Imaging Features of PI-RADS 4 or 5: Influence on Tumor Targeting.PI-RADS 4或5的新型经直肠超声技术及成像特征：对肿瘤靶向的影响
Front Oncol. 2021 Jun 9;11:608409. doi: 10.3389/fonc.2021.608409. eCollection 2021.
2
Transrectal ultrasound features and biopsy outcomes of transition PI-RADS 5.经直肠超声特征与 PI-RADS 5 转化的活检结果。
Acta Radiol. 2022 Apr;63(4):559-565. doi: 10.1177/02841851211018775. Epub 2021 May 22.
3
Update: PI-RADS Version 2.1-A Pictorial Update.更新：PI-RADS第2.1版——图像更新。
经直肠超声引导下对PI-RADS 3-5类索引病变进行靶向活检以减少Gleason评分低估：一项倾向评分匹配分析
Front Oncol. 2022 Jan 24;11:824204. doi: 10.3389/fonc.2021.824204. eCollection 2021.
Radiographics. 2020 Nov-Dec;40(7):E33-E37. doi: 10.1148/rg.2020190207.
4
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion.在多参数磁共振成像呈阳性的患者中使用生物标志物：4K评分可预测索引病灶外癌症的存在。
Int J Urol. 2021 Jan;28(1):47-52. doi: 10.1111/iju.14385. Epub 2020 Sep 27.
5
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD).基于前列腺磁共振成像结局数据库（PROMOD）的多中心回顾性研究：应用前列腺特异性抗原密度和磁共振成像联合进行前列腺活检决策规划
Eur Urol Oncol. 2021 Dec;4(6):971-979. doi: 10.1016/j.euo.2020.08.014. Epub 2020 Sep 21.
6
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study.系统活检在临床怀疑前列腺癌行双参数 MRI 靶向活检男性中的附加价值：多机构外部验证研究。
World J Urol. 2021 Jun;39(6):1879-1887. doi: 10.1007/s00345-020-03393-8. Epub 2020 Aug 10.
7
Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer.系统评价和荟萃分析比较了认知与影像引导融合前列腺活检在前列腺癌检测中的应用。
Urol Oncol. 2020 Sep;38(9):734.e19-734.e25. doi: 10.1016/j.urolonc.2020.03.020. Epub 2020 Apr 19.
8
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.MRI 靶向、系统和联合活检在前列腺癌诊断中的应用。
N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.
9
New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions.经直肠超声针对PI-RADS 4和5类病变的新型活检技术及影像特征
J Clin Med. 2020 Feb 15;9(2):530. doi: 10.3390/jcm9020530.
10
The optimal core number and site for MRI-targeted biopsy of prostate? A systematic review and pooled analysis.前列腺MRI靶向活检的最佳核心数量和部位？一项系统评价与汇总分析。
Minerva Urol Nefrol. 2020 Apr;72(2):144-151. doi: 10.23736/S0393-2249.20.03639-5. Epub 2020 Jan 29.